Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
29.60B | 29.87B | 30.17B | 28.44B | 26.80B | 24.43B | Gross Profit |
10.97B | 10.68B | 10.61B | 10.95B | 9.96B | 8.95B | EBIT |
3.71B | 3.58B | 3.26B | 3.76B | 3.21B | 2.42B | EBITDA |
4.29B | 4.79B | 4.03B | 4.86B | 3.03B | 3.22B | Net Income Common Stockholders |
2.60B | 2.63B | 2.06B | 2.76B | 1.54B | 1.82B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
20.64B | 21.77B | 20.12B | 20.50B | 19.77B | 200.55M | Total Assets |
63.78B | 62.54B | 60.38B | 59.23B | 57.29B | 55.26B | Total Debt |
137.00M | 190.96M | 295.58M | 112.10M | 46.38M | 123.00M | Net Debt |
-20.10B | -21.28B | -19.83B | -20.09B | -19.12B | -18.15B | Total Liabilities |
7.89B | 7.92B | 7.60B | 7.84B | 7.41B | 123.22M | Stockholders Equity |
55.89B | 54.63B | 52.77B | 51.39B | 49.87B | 48.38B |
Cash Flow | Free Cash Flow | ||||
1.18B | 2.67B | 421.99M | 1.72B | 2.61B | 1.82B | Operating Cash Flow |
2.13B | 3.77B | 2.62B | 3.09B | 3.22B | 2.61B | Investing Cash Flow |
-2.32B | -1.14B | -2.18B | -736.74M | -1.70B | -1.08B | Financing Cash Flow |
-1.05B | -1.21B | -516.08M | -1.12B | -650.75M | -563.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥39.01B | 7.90 | 5.01% | 2.11% | 25.18% | ||
76 Outperform | ¥37.73B | 16.03 | 3.86% | 13.35% | 36.30% | ||
71 Outperform | ¥34.52B | 11.70 | 2.72% | -0.44% | 11.35% | ||
71 Outperform | ¥42.90B | 8.23 | 5.30% | 3.16% | ― | ||
70 Outperform | ¥35.19B | 12.80 | 2.89% | 16.06% | 120.22% | ||
68 Neutral | ¥33.03B | 3.52 | 4.20% | 0.79% | 104.91% | ||
50 Neutral | $2.00B | -1.14 | -21.15% | 3.68% | 2.17% | -31.00% |